Table 2 The characteristics of recurrent cases
Patient | Age/sex | Max tumor size(mm) | ETE | No. of foci | Primary tumor laterality | TNM stage | Sum diameter of all tumors | CLNR | CLNM | Initial operation | Time to recurrence (month) | Site of locoregional recurrence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 42/F | 0.8 | + | 4 | L | I | 1.9 | 1/6 | + | HT | 5 | Contralateral lobe |
2 | 56/M | 0.4 | − | 2 | L | III | 0.8 | 3/5 | + | HT | 78 | Contralateral lobe |
3 | 67/F | 0.5 | − | 4 | L | III | 1.8 | 1/6 | + | HT | 25 | Contralateral lobe |
4 | 34/M | 0.5 | − | 2 | L | I | 0.7 | 1/6 | + | HT | 92 | Contralateral lobe |
5 | 37/M | 0.7 | − | 3 | R | I | 1.7 | 0/5 | − | HT | 35 | Contralateral lobe |
6 | 71/F | 0.5 | − | 2 | L | III | 0.9 | 4/5 | + | HT | 37 | Ipsilateral central |
7 | 65/F | 0.4 | − | 3 | L | I | 1.1 | 0/4 | − | HT | 48 | Contralateral lobe |
8 | 43/M | 0.3 | − | 3 | R | I | 0.9 | 1/5 | + | HT | 63 | Contralateral lobe |
9 | 47/M | 0.9 | − | 2 | L | III | 1.6 | 1/8 | + | HT | 66 | Contralateral lobe |
10 | 48/F | 0.4 | − | 2 | R | III | 0.7 | 3/7 | + | HT | 73 | Contralateral lobe |
11 | 51/M | 0.4 | − | 5 | R | III | 1.9 | 3/5 | + | HT | 83 | Contralateral lobe |
12 | 52/F | 0.9 | + | 2 | R | III | 1.3 | 2/6 | + | HT | 89 | Contralateral lobe |
13 | 24/M | 0.8 | − | 4 | R | I | 2.2 | 2/9 | + | HT | 103 | Contralateral lobe |
14 | 39/F | 0.8 | + | 3 | R | I | 1.1 | 3/11 | + | HT | 91 | Contralateral lobe |
15 | 65/M | 0.3 | − | 2 | R | III | 0.6 | 1/8 | + | HT | 67 | Contralateral lobe |
16 | 48/F | 0.5 | + | 3 | L | IV | 1.4 | 1/11 | + | TT | 81 | Contralateral central |
17 | 66/F | 0.5 | + | 3 | R | IV | 1.4 | 2/4 | + | TT | 102 | Ipsilateral lateral |